Avance Biosciences offers Illumina’s TruSeq Amplicon – Cancer Panel (TSACP) to support cancer research. The TSACP is a highly multiplexed targeted resequencing assay for detecting somatic mutations, such as BRAF, KRAS, and EGFR. Leveraging Illumina’s MiSeq sequencing platform and Avance Biosciences extensive experience in next generation DNA sequencing, you can now get your entire cancer research projects accomplished in days instead of months.
Genomics & Biological Services
The following genes are included in the panel